Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Pharmacological stabilization of TYK2 kinase could treat multiple immune-mediated diseases

Aug. 14, 2019

Good news, bad news macrophages identified in arthritis

Aug. 13, 2019

FDA approves Turalio as first therapy for rare and debilitating joint tumor

Aug. 5, 2019

First patient dosed in phase IIa study of ABX-464 for the treatment of RA

Aug. 2, 2019

BMP pathway blockade is a potential therapeutic approach for osteoarthritis

July 30, 2019

Remegen's phase II study of RC-18 meets primary endpoint in SLE

July 15, 2019

UCB studies rozanolixizumab in phase III for generalized myasthenia gravis

July 12, 2019

Naive B cells have tell-tale signature in lupus

July 12, 2019

Bristol-Myers Squibb patents TLR7, TLR8 and/or TLR9 antagonists

July 5, 2019

ImmuPharma reports open-label extension study results for Lupuzor in SLE

June 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...